Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lissbrant, E.
Right arrow Articles by Bergh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lissbrant, E.
Right arrow Articles by Bergh, A.

Journal of Andrology, Vol 18, Issue 4 385-392, Copyright © 1997 by The American Society of Andrology

JOURNAL ARTICLE

Localization and effects of calcitonin gene-related peptide in the testicular vasculature of the rat

E. Lissbrant, O. Collin and A. Bergh
Department of Pathology, Umea University, Sweden.

Using laser Doppler flowmetry, the effects of unilateral intratesticular injection of calcitonin gene-related peptide (CGRP) and CGRP8-37, a CGRP-receptor antagonist, on right- and left-testicular blood flow and mean arterial pressure were studied on anesthetized adult rats. Calcitonin gene-related peptide in doses of 5 and 50 ng increased blood flow 37 +/- 11% (mean +/- SEM, P < 0.05) and 30 +/- 5% at 5 mm, but not 15 mm, away from the injection site, respectively. They did not influence mean arterial pressure nor blood flow in the contralateral testis. Five-hundred nanogram doses increased testicular blood flow in the injected testis at a point 15 mm away from the injection site (22 +/- 3%, P < 0.05) and caused a slight decrease in mean arterial pressure (-12 +/- 3%, P < 0.05). The highest dose, 5 micrograms, caused a large (-39 +/- 3%, P < 0.05) fall in mean arterial pressure within 1 minute after injection, and testicular blood flow was reduced in both the injected (-9 +/- 2%, P < 0.05, 15 mm away from injection site) and contralateral testis (-20 +/- 5%, P < 0.05). Pretreatment with 500 ng of the receptor antagonist, CGRP8-37, did not significantly attenuate the blood flow increasing affect of 50 ng CGRP, nor did 50 micrograms CGRP 8-37 (given alone) influence basal testicular blood flow in the injected testis. Using Immunohistochemistry, CGRP-containing nerves were observed in the superior and interior spermatic nerves, in the testicular artery, and in the veins leaving the testis but not in intratesticular blood vessels. Conclusions: 1) CGRP is a potent vasodilator in the testicular vasculature and it may be involved in the local regulation of testicular blood flow: 2) the testis has limited capacity to autoregulate and is consequently unable to maintain a constant testicular blood flow during large and rapid reductions in blood pressure, and 3) the local and systemic effects of vasodilators act in opposite directions in the testis.


This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
A. Bergh, O. Collin, and E. Lissbrant
Effects of Acute Graded Reductions in Testicular Blood Flow on Testicular Morphology in the Adult Rat
Biol Reprod, January 1, 2001; 64(1): 13 - 20.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. R. Chiocchio, A. M. Suburo, E. Vladucic, B. C. Zhu, E. Charreau, E. E. Décima, and J. H. Tramezzani
Differential Effects of Superior and Inferior Spermatic Nerves on Testosterone Secretion and Spermatic Blood Flow in Cats
Endocrinology, March 1, 1999; 140(3): 1036 - 1043.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
W. Balkan, E. L. Oates, G. A. Howard, and B. A. Roos
Testes Exhibit Elevated Expression of Calcitonin Gene-Related Peptide Receptor Component Protein
Endocrinology, March 1, 1999; 140(3): 1459 - 1469.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The American Society of Andrology.